The Director or Tumour Microenvironment (TME) Research will independently lead the design, development and management of a portfolio of discovery research projects aimed at enhancing existing pipeline assets or developing new products that address unmet clinical & commercial needs. This role is pivotal in driving innovation that adds value to Telix’s pipeline and supports long-term strategic objectives. Leveraging deep expertise in TME, cancer biology, radiobiology and oncology, the Director will identify and prioritize opportunities to improve treatment options—whether by expanding indications for current products, optimizing their performance or identifying new cancer targets to create novel diagnostic and therapeutic radiolabeled agents. Working closely with VP, Discovery Science, commercial leadership, Key Opinion Leaders, collaborators, and strategic partners, the Director will stay at the forefront of TME advancements, the field of cancer targets to shape a research theme aligned with Telix’s needs. Other key responsibilities include developing a long-term research strategy, conducting due diligence on new opportunities, and evaluating the feasibility of new assets for progression into preclinical and early-stage development. This role aims to contribute to Telix’s future pipeline by delivering impactful research that both supports clinical innovation that is meaningful to patients and provides commercial success for shareholders.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
251-500 employees